An Observational Study from Long-Term AAV Re-administration in Two Hemophilia Dogs-Reference-Cited by-同舟云学术

An Observational Study from Long-Term AAV Re-administration in Two Hemophilia Dogs

Published:2018-09 Issue: Volume:10 Page:257-267
ISSN:2329-0501
Container-title:Molecular Therapy - Methods & Clinical Development
language:en
Short-container-title:Molecular Therapy - Methods & Clinical Development

Author:

Sun Junjiang,Shao Wenwei,Chen Xiaojing,Merricks Elizabeth P.,Wimsey Lauren,Abajas Yasmina L.,Niemeyer Glenn P.,Lothrop Clinton D.,Monahan Paul E.,Samulski R. Jude,Nichols Timothy C.,Li Chengwen

Funder

NIH

Asklepios BioPharmaceutical

Publisher

Elsevier BV

Subject

Genetics,Molecular Biology,Molecular Medicine

Reference52 articles.

1. First AAV gene therapy poised for landmark approval;Smalley;Nat. Biotechnol.,2017

2. Early clinical data raise the bar for hemophilia gene therapies;Dolgin;Nat. Biotechnol.,2016

3. 2017 Clinical trials update: Innovations in hemophilia therapy;Hartmann;Am. J. Hematol.,2016

4. A Cure For Hemophilia: the Promise Becomes a Reality;Herzog;Mol. Ther.,2016

5. Clinical development of gene therapy: results and lessons from recent successes;Kumar;Mol. Ther. Methods Clin. Dev.,2016

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recombinant adeno-associated virus 8 vector in gene therapy: Opportunities and challenges;Genes & Diseases;2024-01

2. Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer;BioDrugs;2023-03-02

3. Antibody-based protection against respiratory syncytial virus in mice and their offspring through vectored immunoprophylaxis;Gene Therapy;2023-02-02

4. rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis;Frontiers in Immunology;2022-10-27

5. Serotype-specific transduction of canine joint tissue explants and cultured monolayers by self-complementary adeno-associated viral vectors;Gene Therapy;2022-10-20